Squarepoint Ops LLC Biomarin Pharmaceutical Inc Transaction History

Squarepoint Ops LLC

  • $99.2 Billion
  • Q4 2024

A detailed history of Squarepoint Ops LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Squarepoint Ops LLC holds 693,138 shares of BMRN stock, worth $49.9 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
693,138
Previous 204,526 238.9%
Holding current value
$49.9 Million
Previous $14.4 Million 216.91%
% of portfolio
0.05%
Previous 0.02%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$61.93 - $70.49 $30.3 Million - $34.4 Million
488,612 Added 238.9%
693,138 $45.6 Million
Q3 2024

Nov 14, 2024
BUY
$69.02 - $93.84 $6.96 Million - $9.46 Million
100,841 Added 97.26%
204,526 $14.4 Million
Q2 2024

Aug 14, 2024
SELL
$74.43 - $92.22 $56.4 Million - $69.9 Million
-757,532 Reduced 87.96%
103,685 $8.54 Million
Q1 2024

May 15, 2024
BUY
$83.81 - $99.0 $48.8 Million - $57.7 Million
582,506 Added 209.0%
861,217 $75.2 Million
Q4 2023

Feb 14, 2024
SELL
$76.22 - $98.51 $2.94 Million - $3.8 Million
-38,580 Reduced 12.16%
278,711 $26.9 Million
Q2 2023

Aug 14, 2023
BUY
$86.68 - $100.3 $12.6 Million - $14.6 Million
145,932 Added 85.16%
317,291 $27.5 Million
Q1 2023

May 15, 2023
SELL
$87.74 - $117.27 $331,130 - $442,576
-3,774 Reduced 2.15%
171,359 $16.7 Million
Q4 2022

Feb 14, 2023
BUY
$80.93 - $108.63 $12.3 Million - $16.5 Million
151,541 Added 642.34%
175,133 $18.1 Million
Q3 2022

Nov 14, 2022
BUY
$82.16 - $96.94 $1.94 Million - $2.29 Million
23,592 New
23,592 $2 Million
Q2 2022

Aug 15, 2022
SELL
$71.48 - $86.85 $15.6 Million - $19 Million
-218,758 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$74.28 - $92.69 $2.88 Million - $3.59 Million
-38,713 Reduced 15.04%
218,758 $16.9 Million
Q4 2021

Feb 14, 2022
BUY
$71.72 - $91.47 $4.31 Million - $5.5 Million
60,156 Added 30.49%
257,471 $22.7 Million
Q3 2021

Nov 15, 2021
BUY
$74.77 - $85.47 $8.12 Million - $9.28 Million
108,567 Added 122.33%
197,315 $15.3 Million
Q2 2021

Aug 16, 2021
SELL
$75.51 - $84.79 $2.82 Million - $3.16 Million
-37,305 Reduced 29.59%
88,748 $7.41 Million
Q1 2021

May 17, 2021
BUY
$74.73 - $90.69 $5.1 Million - $6.19 Million
68,303 Added 118.27%
126,053 $9.52 Million
Q4 2020

Feb 16, 2021
BUY
$72.61 - $90.2 $2.32 Million - $2.88 Million
31,884 Added 123.27%
57,750 $5.06 Million
Q3 2020

Nov 16, 2020
SELL
$71.87 - $131.03 $3.14 Million - $5.73 Million
-43,736 Reduced 62.84%
25,866 $1.97 Million
Q2 2020

Aug 14, 2020
SELL
$79.55 - $124.22 $4.1 Million - $6.41 Million
-51,583 Reduced 42.57%
69,602 $8.59 Million
Q1 2020

May 15, 2020
SELL
$71.37 - $96.85 $17.2 Million - $23.4 Million
-241,492 Reduced 66.59%
121,185 $10.2 Million
Q4 2019

Feb 14, 2020
BUY
$64.27 - $86.37 $19.4 Million - $26 Million
301,244 Added 490.36%
362,677 $30.7 Million
Q3 2019

Nov 14, 2019
SELL
$67.4 - $85.11 $3.92 Million - $4.95 Million
-58,184 Reduced 48.64%
61,433 $4.14 Million
Q2 2019

Aug 14, 2019
BUY
$80.35 - $93.9 $1.09 Million - $1.28 Million
13,582 Added 12.81%
119,617 $10.2 Million
Q1 2019

May 15, 2019
BUY
$84.2 - $98.62 $8.57 Million - $10 Million
101,802 Added 2404.96%
106,035 $9.42 Million
Q4 2018

Feb 14, 2019
BUY
$80.14 - $106.07 $339,232 - $448,994
4,233 New
4,233 $360,000
Q4 2017

Feb 14, 2018
SELL
$80.76 - $95.13 $4.48 Million - $5.28 Million
-55,529 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$80.6 - $94.95 $4.48 Million - $5.27 Million
55,529
55,529 $5.17 Million

Others Institutions Holding BMRN

# of Institutions
627
Shares Held
183M
Call Options Held
2M
Put Options Held
1.67M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email